Dimensional Fund Advisors LP Sells 98,794 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Dimensional Fund Advisors LP lowered its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 2.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,324,367 shares of the company's stock after selling 98,794 shares during the quarter. Dimensional Fund Advisors LP owned about 3.60% of Acadia Healthcare worth $258,505,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Vaughan Nelson Investment Management L.P. acquired a new position in Acadia Healthcare during the 4th quarter worth approximately $24,157,000. OFI Invest Asset Management increased its position in shares of Acadia Healthcare by 290.5% during the third quarter. OFI Invest Asset Management now owns 331,129 shares of the company's stock worth $21,990,000 after acquiring an additional 246,322 shares in the last quarter. Jennison Associates LLC lifted its position in Acadia Healthcare by 26.1% in the 4th quarter. Jennison Associates LLC now owns 1,148,755 shares of the company's stock valued at $89,327,000 after acquiring an additional 238,114 shares in the last quarter. California Public Employees Retirement System increased its holdings in Acadia Healthcare by 112.6% during the 3rd quarter. California Public Employees Retirement System now owns 368,382 shares of the company's stock worth $25,901,000 after purchasing an additional 195,130 shares in the last quarter. Finally, Kingdon Capital Management L.L.C. purchased a new stake in shares of Acadia Healthcare in the third quarter worth approximately $12,058,000.

Wall Street Analyst Weigh In

ACHC has been the subject of several recent research reports. Cantor Fitzgerald reiterated a "neutral" rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, March 5th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating and set a $70.00 price target on the stock in a research report on Thursday, April 25th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research report on Monday, March 4th. Bank of America dropped their target price on shares of Acadia Healthcare from $105.00 to $90.00 and set a "buy" rating on the stock in a research report on Thursday, May 2nd. Finally, Barclays reduced their target price on Acadia Healthcare from $100.00 to $91.00 and set an "overweight" rating for the company in a report on Thursday, May 2nd. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $88.89.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC traded down $0.34 during trading on Tuesday, hitting $71.32. 820,498 shares of the company were exchanged, compared to its average volume of 658,501. Acadia Healthcare Company, Inc. has a 52-week low of $64.74 and a 52-week high of $87.77. The stock has a 50 day moving average of $74.62 and a 200 day moving average of $77.28. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The company has a market cap of $6.62 billion, a PE ratio of -509.39, a P/E/G ratio of 2.13 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The firm had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The company's revenue for the quarter was up 9.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.75 earnings per share. As a group, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.55 EPS for the current year.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the company's stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.00% of the company's stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.